Sirolimus and alcohol: what actually happens if you mix them

Last updated 2026-07-30

does sirolimus interact with alcohol directly

There's no pharmacokinetic interaction between ethanol and sirolimus that's been documented in the FDA prescribing information or in transplant pharmacology literature. Sirolimus (brand name Rapamune, also sold as the generic and as Fyarro/Hyftor for other indications) is metabolized primarily by the liver enzyme CYP3A4, and alcohol doesn't compete for that pathway the way, say, grapefruit juice does ^[1]. The official Rapamune label lists extensive drug interactions (CYP3A4 inhibitors like ketoconazole, inducers like rifampin, and specific warnings against grapefruit juice) but does not list alcohol as a contraindicated substance ^[1]. That's different from something like metronidazole or certain cephalosporins, which cause a genuine disulfiram-like reaction (flushing, vomiting, rapid heartbeat) when combined with alcohol. Sirolimus doesn't do that. If you have a glass of wine on rapamycin, you won't get sick from the combination itself. The caution here isn't about a chemical reaction. It's about stacking two things that both stress the liver and both suppress or modulate immune and metabolic function. That's a cumulative-load problem, not an acute-poisoning problem, and it deserves to be treated that way rather than dismissed.

why the liver matters more with sirolimus than with most drugs

Sirolimus is cleared almost entirely by hepatic metabolism, and the FDA label carries a specific dose adjustment warning for people with hepatic impairment: for adults with mild to moderate hepatic impairment, the maintenance dose should be reduced by 33%, and for severe hepatic impairment it should be reduced by 50%, with therapeutic drug monitoring used to guide further adjustment ^[1]. That single fact tells you how liver-dependent this drug is. Alcohol, especially at heavy or chronic levels, is the most common cause of preventable liver damage in the general population. The CDC's Alcohol-Related Disease Impact program tracks deaths attributable to excessive alcohol use across the U.S., and the NIAAA notes that drinking above recommended limits raises the risk of fatty liver, hepatitis, and cirrhosis over time ^{[2] [3]}. None of that is sirolimus-specific, but if your liver is already working harder to clear a drug that depends on it, adding a second liver-taxing habit on top isn't a neutral choice. For someone on a low, intermittent longevity-style dose (commonly 2-6 mg once weekly, well below the roughly 2 mg/day chronic transplant dose), the liver load from the drug itself is modest most weeks. But if you also drink heavily on non-dosing days, you're not really getting a lower-risk protocol. You're just moving the risk around.

can you drink alcohol while taking rapamycin for longevity

Occasional, moderate drinking (the NIAAA defines moderate as up to 1 drink per day for women and up to 2 for men) is unlikely to cause a dangerous interaction with a typical off-label intermittent sirolimus protocol, but nobody has run a controlled human trial testing this combination specifically, so this is a judgment call based on general pharmacology, not a study finding ^[3]. The honest answer is that this is unstudied territory dressed up as a question with a clean yes/no answer. There is no completed human trial on intermittent low-dose sirolimus for lifespan extension at all, let alone one that varies alcohol intake as a study arm. Everything said here is extrapolated from transplant-dose pharmacology, general hepatology, and basic pharmacokinetics, not from data on the exact population asking this question. That gap matters, and it's worth being upfront about it rather than pretending otherwise. What's reasonable, based on that extrapolation: keep drinking light to moderate, avoid binge drinking, and don't drink heavily on or immediately before your dosing day, since that's when drug levels and liver processing demand peak. If you already have any liver enzyme elevation, fatty liver, or a personal or family history of liver disease, that changes the calculus meaningfully and is worth flagging to whatever provider is reviewing your protocol.

does alcohol make sirolimus's immunosuppressive effects worse

Alcohol itself dampens immune function, and combining it with a drug that is FDA-approved specifically because it suppresses immune response (to prevent organ transplant rejection) means you're layering two immune-suppressing exposures rather than one ^{[1] [4]}. The NIAAA describes how both acute heavy drinking and chronic alcohol use impair innate and adaptive immune responses, increase susceptibility to pneumonia and other infections, and slow wound healing ^[4]. Sirolimus's own label carries a boxed warning about increased susceptibility to infection and the possible development of lymphoma and other malignancies with immunosuppression, which is the core tradeoff of the drug at any dose ^[1]. At transplant doses this risk is well characterized because transplant recipients are followed closely for exactly this reason. At the low, weekly, off-label doses used in longevity protocols, immune suppression is presumed to be much smaller (some of the animal and small human safety data even show improved vaccine response at low intermittent doses, which is part of why researchers are interested in this dosing pattern at all) but it isn't zero, and it isn't well quantified in this specific population ^[1]. Add alcohol, and you're asking an immune system that's already handling one suppressive input to also handle another. If you get sick often, have an upcoming surgery, or are elderly with reduced immune reserve to begin with, this is where the combination stops being theoretical and starts being a real practical risk.

does alcohol worsen sirolimus mouth ulcers

Mouth ulcers (technically stomatitis) are one of the most commonly reported side effects of sirolimus at both transplant and off-label doses, and alcohol is a well-known direct irritant to oral mucosa, so combining the two is likely to make ulcers more painful and possibly slower to heal, even though this specific combination hasn't been studied directly. In key Rapamune trials, mouth ulcers were reported in roughly 30-38% of transplant patients depending on the dose and combination regimen, making it one of the signature side effects of the drug ^{[1] [5]}. Anecdotally, in the low-dose longevity community and in small human safety studies like the PEARL trial, oral ulcers remain one of the most frequently cited adverse effects even at once-weekly dosing far below the transplant range ^[1]. Alcohol, particularly spirits, wine, and anything acidic or carbonated, is a known mucosal irritant that can sting or worsen existing mouth sores independent of any drug. If you're already dealing with sirolimus-related ulcers, alcohol is likely to make eating and drinking more uncomfortable during a flare, and it's reasonable to avoid it, or at least dilute and avoid straight spirits, until the ulcer heals. This is a comfort and healing-time issue more than a safety issue, but it's the side effect people complain about most, so it's worth naming directly.

how does alcohol affect the metabolic side of sirolimus

Sirolimus is well known for causing dose-dependent metabolic changes, including elevated triglycerides, elevated LDL cholesterol, and in some patients new-onset or worsened insulin resistance and hyperglycemia, all of which are listed in the FDA label under warnings and precautions ^[1]. Alcohol, especially in more than modest amounts, independently raises triglycerides and can worsen glucose control, so the two effects move in the same direction rather than canceling out ^[3]. In the Rapamune label's adverse reaction tables, hypertriglyceridemia and hypercholesterolemia are among the most frequently reported laboratory abnormalities, occurring in a large share of treated transplant patients, with triglyceride elevations sometimes severe enough to require lipid-lowering therapy ^[1]. For someone on a low-dose weekly protocol, the magnitude is presumed smaller, but it hasn't been characterized in a large controlled human trial, so caution is reasonable rather than optional. If you already run high triglycerides, have prediabetes, or drink more than lightly on a regular basis, it's worth getting a fasting lipid panel and glucose checked before starting sirolimus and again a few months in, specifically because both alcohol and the drug push those numbers in the same direction. This is exactly the kind of interaction where a provider reviewing your labs matters more than a generic interaction checker.

is there human trial data on sirolimus, alcohol, and lifespan at all

No. There is no completed human lifespan-extension trial for sirolimus, with or without alcohol as a variable, and that absence is the central fact anyone evaluating this drug for longevity needs to sit with. The strong evidence for lifespan extension comes almost entirely from mice. The NIA Interventions Testing Program (ITP), running across three sites (Jackson Laboratory, University of Michigan, and UT Health San Antonio), has repeatedly found that rapamycin extends median lifespan in genetically heterogeneous mice, with effects seen even when treatment starts relatively late in life, at doses and schedules that varied across cohorts ^[6]. One widely cited ITP result found roughly 9-14% increases in median lifespan in mice started on rapamycin at 20 months of age, with larger effects in some cohorts and at higher doses ^[6]. That's a genuinely strong, replicated animal signal, and it's the reason rapamycin is one of the most-discussed longevity compounds in academic aging biology. But mice are not humans, the ITP protocols didn't test alcohol interactions, and there is no equivalent multi-year, mortality-endpoint human trial. The closest human data is small and short: the PEARL trial (Kaeberlein et al.) looked at 6- and 8-week low-dose regimens in a few dozen adults and found the drug tolerable with some improvements in surrogate markers, not lifespan outcomes, over a study period measured in weeks, not years ^[1]. If someone tells you human lifespan data confirms the mouse findings, that's not accurate as of now, and any advice about alcohol interactions in this population is necessarily extrapolated rather than proven.

what does a provider actually recommend about drinking on sirolimus

A provider reviewing an off-label sirolimus protocol is generally going to ask about baseline liver function, current drinking habits, and any history of infections or metabolic issues before greenlighting the combination at all, rather than giving a blanket yes or no. That individualized check is the point of provider review rather than self-directed dosing. Practical, conservative guidance that tracks the pharmacology above: keep alcohol light to moderate, avoid heavy or binge drinking, skip alcohol on your dosing day if you want the cleanest read on how your body handles the drug, and get baseline and follow-up liver enzymes and a lipid panel done regardless of your drinking habits, since sirolimus affects both independent of alcohol ^[1]. If you already drink most days or have any liver concern, that's worth a direct conversation before starting, not an assumption that it'll be fine. Sirolimus Rx works with a provider-reviewed process specifically so questions like this get answered against your actual labs and history rather than a generic label insert, with prescriptions filled through a licensed pharmacy partner rather than any unregulated source. If you're deciding whether to start at all, it's worth reading is sirolimus worth it and sirolimus pros and cons first, since the alcohol question is a small piece of a much bigger risk-benefit picture.

sirolimus vs rapamycin: does the name change anything about the alcohol question

No. Sirolimus and rapamycin are the same molecule; sirolimus is the generic drug name and rapamycin is the original name given to the compound isolated from Streptomyces hygroscopicus found on Easter Island (Rapa Nui), which is where the name comes from ^[7]. Rapamune is the brand name for the FDA-approved oral formulation. Newer formulations like Fyarro (a nanoparticle albumin-bound form) and Hyftor (a topical gel for tuberous sclerosis skin lesions) are also sirolimus, approved for different specific indications, not for longevity ^[8] . None of the alcohol guidance changes based on which name or brand is used, since it's the same active compound driving liver metabolism, immune suppression, and metabolic effects regardless of formulation, though a topical gel like Hyftor has essentially no systemic alcohol interaction concern given minimal systemic absorption. If you're comparing sirolimus against other longevity compounds or reading about outcomes, it helps to know you're reading about one drug under several names, so a study on 'rapamycin' in mice and a prescription for 'sirolimus' at a pharmacy are the same substance.

Frequently asked questions

Can I drink alcohol the same day I take my sirolimus dose?

There's no documented acute reaction, but the dosing day is when drug levels peak and your liver is working hardest to clear the drug. Many providers suggest skipping alcohol on dosing day specifically, both to avoid extra liver load and to get a cleaner read on side effects like nausea or fatigue that could otherwise be blamed on alcohol.

Does alcohol cancel out the benefits of sirolimus?

There's no human trial showing sirolimus produces lifespan benefits at all, so there's nothing proven to 'cancel out.' What's known is that alcohol and sirolimus both affect triglycerides, liver load, and immune function in the same direction, so heavy drinking works against whatever off-label benefit someone hopes to get.

Is sirolimus and alcohol dangerous like Antabuse (disulfiram) and alcohol?

No. Disulfiram causes a specific enzyme-blocking reaction that makes alcohol toxic and causes flushing, vomiting, and rapid heartbeat. Sirolimus doesn't inhibit that enzyme (aldehyde dehydrogenase) and has no documented disulfiram-like reaction with alcohol in the FDA label or clinical literature.

Will alcohol make my sirolimus mouth ulcers worse?

Likely yes, though it hasn't been studied as a specific combination. Alcohol is a known irritant to oral mucosa, and mouth ulcers (stomatitis) are one of the most common sirolimus side effects, reported in roughly 30-38% of transplant patients in key trials. Avoiding alcohol during an active ulcer flare is a reasonable, low-cost precaution.

Does sirolimus affect how my body processes alcohol?

Not directly through a shared metabolic pathway; sirolimus is cleared by CYP3A4 and alcohol mainly through alcohol dehydrogenase, so they don't compete head-on. The real overlap is that both stress the liver overall and both affect triglycerides and immune function, which is a cumulative burden issue rather than a blocked-metabolism issue.

How much alcohol is considered safe while on low-dose sirolimus?

There's no dedicated study to cite a specific safe threshold for this combination. Using general NIAAA moderate-drinking guidance (up to 1 drink per day for women, up to 2 for men) as a ceiling, rather than a target, is a reasonable conservative approach until better data exists.

Should heavy drinkers avoid sirolimus entirely?

Anyone who drinks heavily or has any diagnosed liver disease should discuss this specifically with a provider before starting sirolimus, since the drug's dosing is adjusted for hepatic impairment (33% dose reduction for mild-moderate, 50% for severe, per the FDA label) and heavy drinking raises liver disease risk over time.

Does alcohol increase infection risk on top of sirolimus's immunosuppression?

Plausibly yes. Alcohol independently impairs immune function, and sirolimus is FDA-approved specifically for its immunosuppressive effect in transplant patients. At low, once-weekly longevity doses, immune suppression is thought to be much smaller, but it hasn't been well quantified, so stacking heavy drinking on top isn't risk-free.

Is there any human data at all on sirolimus, alcohol, and aging?

No completed human lifespan trial exists for sirolimus at all, and none has tested alcohol as a variable. The strongest human data is short-term safety work like the PEARL trial, which ran 6 to 8 weeks and looked at tolerability and surrogate markers, not lifespan or alcohol interactions.

Are rapamycin and sirolimus different drugs with different alcohol interactions?

No, they're the same molecule. Sirolimus is the generic drug name, rapamycin is the original chemical name from the Streptomyces hygroscopicus organism it was isolated from, and Rapamune is the FDA-approved brand. Alcohol guidance is identical regardless of which name is on the bottle.

Can alcohol affect sirolimus blood levels and lab monitoring?

Indirectly, through liver function. Since sirolimus is metabolized hepatically and levels are sometimes monitored by blood trough testing in higher-dose regimens, significant liver strain from heavy drinking could theoretically alter clearance, though this hasn't been directly studied in the low-dose longevity population.

Does drinking alcohol worsen sirolimus's cholesterol and triglyceride effects?

Likely yes. Sirolimus is well documented to raise triglycerides and LDL cholesterol in a dose-dependent way, and alcohol independently raises triglycerides too. Anyone with existing high triglycerides should get a baseline lipid panel before starting and monitor it while drinking any meaningful amount on the drug.

Sources

1. FDA, Rapamune (sirolimus) full prescribing information: Hepatic impairment dosing adjustments, drug interaction list, boxed warning on infection/malignancy risk, and mouth ulcer/lipid adverse reaction rates
2. CDC, Alcohol-Related Disease Impact (ARDI) application: Estimated annual U.S. deaths attributable to excessive alcohol use
3. NIAAA, Alcohol's Effects on the Body: Alcohol impairs innate and adaptive immune function and increases infection susceptibility
4. Kaeberlein et al., PEARL trial results, PMC10166223: Short-term (6-8 week) human safety trial of low-dose intermittent sirolimus, tolerability and surrogate marker findings
5. Harrison et al., Nature 2009, 'Rapamycin fed late in life extends lifespan in genetically heterogeneous mice', PMID 19587680: Rapamycin extends median lifespan in genetically heterogeneous mice across multiple ITP cohorts
6. NIH National Cancer Institute, Sirolimus definition: Sirolimus and rapamycin are the same compound, originally isolated from Streptomyces hygroscopicus
7. FDA, Fyarro (sirolimus protein-bound particles) approval label: Fyarro is an FDA-approved sirolimus formulation for a specific oncology indication, not longevity
8. FDA, Hyftor (sirolimus topical gel) approval label: Hyftor is an FDA-approved topical sirolimus gel for tuberous sclerosis skin lesions